Fmr LLC Atossa Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 17,037 shares of ATOS stock, worth $17,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,037

Previous 9,291 83.37%

Holding current value

$17,037

Previous $6,000 133.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.59 - $1.03 $4,570 - $7,978	7,746 Added 83.37%	17,037 $14,000
Q1 2025 May 12, 2025	SELL	$0.67 - $1.01 $1,341 - $2,022	-2,002 Reduced 17.73%	9,291 $6,000
Q4 2024 Feb 13, 2025	BUY	$0.94 - $1.62 $2,405 - $4,145	2,559 Added 29.3%	11,293 $10,000
Q3 2024 Nov 13, 2024	BUY	$1.09 - $1.52 $5,041 - $7,030	4,625 Added 112.56%	8,734 $13,000
Q2 2024 Aug 13, 2024	SELL	$1.03 - $2.1 $55 - $113	-54 Reduced 1.3%	4,109 $4,000
Q4 2023 Feb 13, 2024	SELL	$0.63 - $0.98 $13 - $20	-21 Reduced 0.5%	4,163 $3,000
Q3 2023 Nov 13, 2023	SELL	$0.74 - $1.35 $370 - $675	-500 Reduced 10.67%	4,184 $3,000
Q2 2023 Aug 11, 2023	SELL	$0.6 - $1.28 $6,552 - $13,977	-10,920 Reduced 69.98%	4,684 $5,000
Q1 2023 May 11, 2023	BUY	$0.59 - $0.91 $7,559 - $11,658	12,812 Added 458.88%	15,604 $11,000
Q4 2022 Feb 13, 2023	BUY	$0.5 - $1.01 $996 - $2,011	1,992 Added 249.0%	2,792 $1,000
Q3 2022 Nov 10, 2022	SELL	$0.82 - $1.14 $3,174 - $4,412	-3,871 Reduced 82.87%	800 $1,000
Q2 2022 Aug 12, 2022	BUY	$0.85 - $1.28 $3,027 - $4,559	3,562 Added 321.19%	4,671 $5,000
Q1 2022 May 13, 2022	BUY	$1.11 - $1.74 $1,230 - $1,929	1,109 New	1,109 $1,000
Q4 2021 Feb 14, 2022	SELL	$1.6 - $3.27 $28 - $58	-18 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.89 - $6.4 $46 - $102	16 Added 800.0%	18 $0
Q2 2021 Aug 13, 2021	BUY	$1.52 - $8.62 $3 - $17	2 New	2 $0

Others Institutions Holding ATOS

# of Institutions

Shares Held

28.6M

Call Options Held

12.7K

Put Options Held

92.9K

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $127M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account